Abstract:Abstract Aims/hypothesis Our aim was to characterise the in-depth metabolic response to aerobic exercise and the impact of residual pancreatic beta cell function in type 1 diabetes. We also aimed to use the metabolome to distinguish individuals with type 1 diabetes with reduced maximal aerobic capacity in exercise defined by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak . Methods Thirty participants with type 1 diabetes (≥3 years duration) and 30 control participants were recruited. Groups did not differ in age or sex. After quantification of peak stimulated C-peptide, participants were categorised into those with undetectable ( 200 pmol/l) residual beta cell function. Maximal aerobic capacity was assessed by $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak test and did not differ between control and type 1 diabetes groups. All participants completed 45 min of incline treadmill walking (60% $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) with venous blood taken prior to exercise, immediately post exercise and after 60 min recovery. Serum was analysed using targeted metabolomics. Metabolomic data were analysed by multivariate statistics to define the metabolic phenotype of exercise in type 1 diabetes. Receiver operating characteristic (ROC) curves were used to identify circulating metabolomic markers of maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) during exercise in health and type 1 diabetes. Results Maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) inversely correlated with HbA 1c in the type 1 diabetes group ( r 2 =0.17, p =0.024). Higher resting serum tricarboxylic acid cycle metabolites malic acid (fold change 1.4, p =0.001) and lactate (fold change 1.22, p =1.23×10 −5 ) differentiated people with type 1 diabetes. Higher serum acylcarnitines (AC) (AC C14:1, F value=12.25, p =0.001345; AC C12, F value=11.055, p =0.0018) were unique to the metabolic response to exercise in people with type 1 diabetes. C-peptide status differentially affected metabolic responses in serum ACs during exercise (AC C18:1, leverage 0.066; squared prediction error 3.07). The malic acid/pyruvate ratio in rested serum was diagnostic for maximal aerobic capacity ( $$\dot{V}{\text{O}}_{\text{2peak}}$$ V ̇ O 2peak ) in people with type 1 diabetes (ROC curve AUC 0.867 [95% CI 0.716, 0.956]). Conclusions/interpretation The serum metabolome distinguishes high and low maximal aerobic capacity and has diagnostic potential for facilitating personalised medicine approaches to manage aerobic exercise and fitness in type 1 diabetes. Graphical Abstract

Type 2 Diabetes Alters Metabolic and Transcriptional Signatures of Glucose and Amino Acid Metabolism During Exercise and Recovery

Physical Exercise as Therapy for Type 2 Diabetes Mellitus: From Mechanism to Orientation

Exercise Response Variations in Skeletal Muscle PCr Recovery Rate and Insulin Sensitivity Relate to Muscle Epigenomic Profiles in Individuals With Type 2 Diabetes

Distinctive exercise-induced inflammatory response and exerkine induction in skeletal muscle of people with type 2 diabetes

An integrative profiling of metabolome and transcriptome in the plasma and skeletal muscle following an exercise intervention in diet-induced obese mice

Metabolomics Studies on Db/db Diabetic Mice in Skeletal Muscle Reveal Effective Clearance of Overloaded Intermediates by Exercise.

Acute Exercise Increases GDF15 and Unfolded Protein Response/Integrated Stress Response in Muscle in Type 2 Diabetes

Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Exercise-induced microbial changes in preventing type 2 diabetes

Metabolomic Profiling Reveals That Exercise Lowers Biomarkers of Cardiac Dysfunction in Rats with Type 2 Diabetes

Physical Exercise and Redox Balance in Type 2 Diabetics: Effects of Moderate Training on Biomarkers of Oxidative Stress and DNA Damage Evaluated through Comet Assay

Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function

Transcriptomic Responses of Skeletal Muscle to Acute Exercise in Diabetic Goto-Kakizaki Rats.

Exercise‐induced improvement of glycemic fluctuation and its relationship with fat and muscle distribution in type 2 diabetes

Transcriptomic Responses of Hypothalamus to Acute Exercise in Type 2 Diabetic Goto-Kakizaki Rats

Exercise-nutrient interactions for improved postprandial glycemic control and insulin sensitivity

Gut Microbiota in the Progression of Type 2 Diabetes and the Potential Role of Exercise: A Critical Review

Impact of physical exercise and caloric restriction in patients with type 2 diabetes: Skeletal muscle insulin resistance and mitochondrial dysfunction as ideal therapeutic targets

Metabolic impairments associated with type 2 diabetes mellitus and the potential effects of exercise therapy: An exploratory randomized trial based on untargeted metabolomics

The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes

High-throughput proteomics uncovers exercise training and type 2 diabetes-induced changes in human white adipose tissue